Skip to main content

Press Releases

May 16, 2023
Washington, D.C. – Today, Congressman Lloyd Doggett (D-Austin), a senior member of the Ways and Means Committee and House Budget Committee, issued the following statement after the Congressional Budget Office (CBO) released an updated estimate of the 10-year cost for extending the expiring individual provisions of the 2017 Trump-GOP Tax Cuts and Jobs Act, which would add about $3 trillion to our Nation’s budget deficit:

May 12, 2023
Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Ranking Member of the House Ways & Means Health Subcommittee, led a group of more than 70 Members in urging the Environmental Protection Agency (EPA) to use its existing authority under the Clean Water Act to protect our drinking water and the environment by strengthening its regulation of microplastic pollution.  

May 11, 2023
Washington, D.C. – Today, Congressman Lloyd Doggett (D-Austin) spoke on the House Floor to oppose Republicans’ so-called “Secure the Border Act,” which does nothing to fix America’s immigration system but would wreck the economy, destroy the asylum system, and criminalize visa overstays.
Issues:Immigration

May 10, 2023

Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-Austin) released the following statement applauding the IRS-issued notice of intent to update the outdated federal limit on the amount of bonds that the Texas’ Permanent School Fund (PSF) can guarantee:


May 3, 2023

Washington, D.C. – U.S. Representative Lloyd Doggett (D-Texas) and U.S. Senator Elizabeth Warren (D-Mass.) led 31 colleagues in urging U.S. Trade Representative Katherine Tai and Secretary of State Antony Blinken to work toward eliminating the Investor-State Dispute Settlement (ISDS) system from existing trade and investment agreements. The letter also requests that the Administration intervene in an ISDS case brought against Honduras by U.S. company Honduras Próspera. 


May 2, 2023
Washington, D.C. – Today, U.S. Representatives Lloyd Doggett (D-TX), ranking member of the House Ways and Means Health Subcommittee, and Nanette Diaz Barragán (D-CA), member of the House Energy & Commerce Health Subcommittee, led a group of 113 Members in urging the Centers for Medicare and Medicaid Services (CMS) to use its existing executive authority to further improve coverage of medically necessary dental care.
Issues:Healthcare

April 28, 2023
Washington, D.C. – Today, U.S. Representatives Lloyd Doggett (D-TX), ranking member of the House Ways and Means Subcommittee on Health, Mike Kelly (R-PA), Chairman of the House Ways and Means Subcommittee on Tax, Danny K. Davis (D-IL), ranking member of the House Ways and Means Subcommittee on Worker and Family Support, and Adrian Smith (R-NE), Chairman of the House Ways and Means Subcommittee on Trade, introduced bipartisan legislation to remove a financial and logistical barrier impairing students from securing higher education opportunities. The Tax Free Pell Grants Act expands the usage of Pell Grants on a tax-free basis, improves coordination with the American Opportunity Tax Credit (AOTC), and ensures students do not lose out on any AOTC benefits.

April 26, 2023
AUSTIN – U.S. Representative Lloyd Doggett (D-Austin) announced more than $1.4 million in federal funding he secured through the Fiscal Year 2023 appropriations process to establish a Cybersecurity Training Center at the Austin Community College (ACC) Rio Grande Campus. 

April 20, 2023
Austin, TX – On Monday, April 24, at 11 AM, U.S. Representative Lloyd Doggett (D-Austin), senior member of the House Ways and Means Committee, will join Austin Community College District (ACC) leaders at the ACC Rio Grande Campus to unveil details of a project to establish a Cybersecurity Training Center at ACC with federal funds Rep. Doggett secured.

April 14, 2023

FOR IMMEDIATE RELEASE: 
April 14, 2023

Leader's Press Office: 202-226-4519

Democrats in Congress File Amicus Brief Urging Supreme Court to Prevent Dangerous Ruling From Restricting Access to Mifepristone Nationwide & Upending FDA Approval Process